Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Besponsa [legacy through FY23] by Quarter
Besponsa (inotuzumab ozogamicin) [legacy through FY23] ($M) ($M)
Pfizer Besponsa [legacy through FY23]: $65M in Q4 2023, up 18.2% from a year earlier. That is the highest of the 16 quarters on record here. No newer figure appears in the documents we track.
Where the Q4 2023 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2024-02-22) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Besponsa (inotuzumab ozogamicin) [legacy through FY23] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2023 | Dec 31, 2023 | 65 | +18.2% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2023 | Oct 1, 2023 | 54 | -1.8% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 59 | +1.7% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 58 | +13.7% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 55 | +17.0% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2022 | Oct 2, 2022 | 55 | +10.0% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2022 | Jul 3, 2022 | 58 | +28.9% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2022 | Apr 3, 2022 | 51 | +2.0% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2021 | Dec 31, 2021 | 47 | -2.1% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2021 | Oct 3, 2021 | 50 | +13.6% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | 45 | -2.2% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | 50 | +13.6% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | 48 | – | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2020 | Sep 27, 2020 | 44 | – | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | 46 | – | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 44 | – | Form 10-Q (filed 2021-05-13) ↗ |
Cite this data
StockData. (2026). Pfizer Besponsa [legacy through FY23] ($M), quarterly Q1 2020–Q4 2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/besponsa-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.